发明名称 PHARMACEUTICAL COMPOSITION IMPROVING ABSORBABILITY THROUGH INTESTINAL TRACT
摘要 PROBLEM TO BE SOLVED: To provide a pharmaceutical composition improving the absorbability through the intestinal tract, containing a compound having a structure represented by general formula [1]. SOLUTION: The pharmaceutical composition includes (a) a compound represented by general formula [1]: R<SP>1</SP>R<SP>2</SP>N-C(=X)-A-B-R<SP>3</SP>or a salt thereof, and (b) a lipophilic substance. The composition improves the absorbability of the compound (a) through the intestinal tract. In the general formula [1], A is -(NR<SP>4</SP>)-, -(CR<SP>5</SP>R<SP>6</SP>)- or the like; B is alkylene or alkenylene; R<SP>1</SP>is alkyl, alkenyl or the like; R<SP>2</SP>is adamantylalkyl or the like; R<SP>3</SP>is unsaturated heterocyclic ring; R<SP>4</SP>, R<SP>5</SP>and R<SP>6</SP>are each H or the like; and X is oxygen atom or the like. COPYRIGHT: (C)2010,JPO&INPIT
申请公布号 JP2010120930(A) 申请公布日期 2010.06.03
申请号 JP20090242956 申请日期 2009.10.22
申请人 SANTEN PHARMACEUT CO LTD 发明人 UMEDA MASAYUKI;KIMURA AKIO;UEDA KENJI;SAKANAKA KOJI
分类号 A61K31/4409;A61K47/14;A61P3/10;A61P11/00;A61P17/00;A61P19/02;A61P19/10;A61P25/00;A61P27/02;A61P27/06;A61P29/00;A61P37/02;A61P37/08;A61P43/00;C07D213/40 主分类号 A61K31/4409
代理机构 代理人
主权项
地址